8 reported that low- to medium-dose ICS showed a trend towards a decreased risk of the composite outcome (OR, 0.95; 95% CI, 0.77–1.19).
← all excerpts
Inhaled Corticosteroid and Secondary Glaucoma: A Meta-analysis of 18 Studies.
1
—
—
8 reported that low- to medium-dose ICS showed a trend towards a decreased risk of the composite outcome (OR, 0.95; 95% CI, 0.77–1.19).